Role of Dopamine on Loss Aversion Behaviour: Study on Parkinsonian Patients

University Hospital, Clermont-Ferrand

Status and phase: Unknown; Phase 4

Conditions: Parkinson's Disease

Treatments: Behavioral: Role of dopamine

Study type: Interventional

Funder types: Other

Identifiers

NCT01780467

CHU-0139

2012-002768-28

Details and patient eligibility

About

Use lay language.

Many decisions involve the possibility of gaining or losing relative to the status quo. The loss aversion behaviour is a cognitive concept explaining that people are more sensitive to the possibility of losing objects or money than they are to the possibility of gaining the same objects or amounts of money.

We hypothesised that dopamine could be involved in the loss aversion behaviour. To highlight this, we have chosen a model of dopaminergic depletion : the Parkinson's disease The primary purpose of this protocol is to study the role of dopamine in the loss aversion phenomenon by comparing brain activity in parkinsonian patient with and without treatment with L Dopa, when they are exposed to mixed (gain/loss) gambles using money.

The second purpose is to highlight the role of a dopamine depletion by comparing patient without treatment vs healthy paired control.

2 groups :

• 20 parkinsonian patients (tested two times : with and without treatment by L dopa)
• 20 healthy paired control

Description of the protocol for patients :

J0 : Inclusion visit (duration : 4h):

• motor assessment (UPDRS)
• neuropsychological and psychiatric assessment (MMS, MATTIS, BREF, Stroop, Ardouin scale, UPPS, MADRS, Hamilton, LARS).

J0+1 day and J0 +2 days : 2 visits of MRI (magnetic resonance imaging) acquisition (with or without treatment) :

Each acquisition was composed by an orientation sequence+ an anatomic sequence + a functional sequence.

For healthy subjects, they have only one visit of 2 hours including a MMS, a MADRS and the MRI acquisitions.

Full description

Use lay language.

Many decisions involve the possibility of gaining or losing relative to the status quo. The loss aversion behaviour is a cognitive concept explaining that people are more sensitive to the possibility of losing objects or money than they are to the possibility of gaining the same objects or amounts of money.

We hypothesised that dopamine could be involved in the loss aversion behaviour. To highlight this, we have chosen a model of dopaminergic depletion : the Parkinson's disease The primary purpose of this protocol is to study the role of dopamine in the loss aversion phenomenon by comparing brain activity in parkinsonian patient with and without treatment with L Dopa, when they are exposed to mixed (gain/loss) gambles using money.

The second purpose is to highlight the role of a dopamine depletion by comparing patient without treatment vs healthy paired control.

2 groups :

• 20 parkinsonian patients (tested two times : with and without treatment by L dopa)
• 20 healthy paired control

Description of the protocol for patients :

J0 : Inclusion visit (duration : 4h):

• motor assessment (UPDRS)
• neuropsychological and psychiatric assessment (MMS, MATTIS, BREF, Stroop, Ardouin scale, UPPS, MADRS, Hamilton, LARS).

J0+1 day and J0 +2 days : 2 visits of MRI (magnetic resonance imaging) acquisition (with or without treatment) :

Each acquisition was composed by an orientation sequence+ an anatomic sequence + a functional sequence.

For healthy subjects, they have only one visit of 2 hours including a MMS, a MADRS and the MRI acquisitions.

Enrollment: 40 estimated patients

Sex: All

Ages: 35 to 75 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Patients :
• Men or women aged between 35 -75 years
• Patients with an idiopathic Parkinson's disease according to UKPDSBB criterias with a disease evolution duration : 5-10 years)
• With fluctuations in end of doses + morning akinesia.
• Non dement (MMS>24 ; Mattis > 130)
• Affiliated to National Health system
• Having given their informed consent

Healthy controls

• Men or women aged between 35 to 75 years
• Non dement (MMS>24 )
• Affiliated to National Health system
• Having given their informed consent

Exclusion criteria

• Patients :
• Patients suffering of an atypical Parkinson syndrome
• Psychiatric pathology
• Tremor form (≥ 3 (item tremor of UPDRS))
• Patients with Impulsive control disorders
• Depression, dementia
• Pregnant
• Under guardianship
• In excluding period for another study
• Any contra-indication to MRI

Healthy subject

• Subject with neurological, psychiatric diseases
• Depression, dementia
• Pregnant
• Under guardianship
• In excluding period for another study
• Any contra-indication to MRI

Trial design

40 participants in 2 patient groups

patients with and without treatment by L dopa)

Experimental group

Description:

to study the role of dopamine in the loss aversion phenomenon by comparing brain activity in parkinsonian patient with and without treatment with L Dopa, when they are exposed to mixed (gain/loss) gambles using money.

Treatment:

Behavioral: Role of dopamine

healthy paired control

Other group

Description:

to highlight the role of a dopamine depletion by comparing patient without treatment vs healthy paired control.

Treatment:

Behavioral: Role of dopamine